Stephen David Prior

Insider Reports History

Entity
Individual
Location
C/O An2 Therapeutics, Inc., 1800 El Camino Real, Suite D, Menlo Park, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Stephen David Prior
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen David Prior:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Strategy Officer Common Stock 61.3K $82.2K $1.34 Feb 26, 2025 Direct
AN2 Therapeutics, Inc. Chief Strategy Officer Stock Option (right to buy) 56K Feb 26, 2025 Direct

Insider Reports Filed by Stephen David Prior

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Feb 26, 2025 2 $0 4 Feb 28, 2025 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Jan 3, 2025 1 -$2.72K 4 Jan 7, 2025 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Nov 4, 2024 2 $0 4 Nov 5, 2024 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Nov 4, 2024 0 $0 3 Nov 5, 2024 Chief Strategy Officer